ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

ClinicalTrials.gov ID: NCT03643159

Public ClinicalTrials.gov record NCT03643159. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 2:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, 180-day Pragmatic Clinical Trial to Measure the Difference in All-cause Hospitalizations for Patients Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Study identification

NCT ID
NCT03643159
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Industry
Enrollment
2 participants

Conditions and interventions

Interventions

  • Abilify MyCite - Digital Medicine System Combination Product
  • Aripiprazole or other oral antipsychotics Drug

Combination Product · Drug

Eligibility (public fields only)

Age range
18 Years to 63 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 27, 2018
Primary completion
Oct 16, 2018
Completion
Oct 16, 2018
Last update posted
Nov 7, 2019

2018

United States locations

U.S. sites
5
U.S. states
4
U.S. cities
5
Facility City State ZIP Site status
Siyan Clinical Research Santa Rosa California 95401
Psychiatric Addiction Curative/PACT Atlanta LLC Decatur Georgia 30030
Georgia Psychiatry and Sleep Smyrna Georgia 30080
Kolade Research Institute Las Vegas Nevada 89109
Signature Research Associates, Inc. Fairlawn Ohio 44333

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03643159, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2019 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03643159 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →